Breast cancer and pregnancy

被引：13
作者：
Leslie, KK
Lange, CA
机构：
[1] Univ New Mexico, Hlth Sci Ctr, Div Maternal Fetal Med, Dept Obstet & Gynecol, Albuquerque, NM 87131 USA
[2] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA
[3] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA
来源：
OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA | 2005年 / 32卷 / 04期
关键词：
D O I：
10.1016/j.ogc.2005.08.010
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
This article addresses a challenging diagnostic and treatment dilemma encountered in the care of pregnant women-breast cancer. The treatment of a breast cancer is significantly affected by an ongoing pregnancy and may result in an increased risk for a poor outcome in the mother. The definition, incidence, mechanism, diagnosis, and treatment of breast cancer associated with pregnancy and the normal physiologic and endocrine changes in the breast during pregnancy that contribute to the difficulty encountered by practitioners in diagnosing and treating the disorder are reviewed. The risks associated with pregnancy after breast cancer treatment and the effect of pregnancy on lifetime risk for breast cancer in the general population and for women with mutations in BRCA1 and BRCA2 are also discussed.
引用
收藏
页码：547 / +
页数：14
相关论文
共 76 条
[1]  
Albain K S, 1994, J Natl Cancer Inst Monogr, P35
[2]   THE SHORT-TERM AND LONG-TERM EFFECT OF A PREGNANCY ON BREAST-CANCER RISK - A PROSPECTIVE-STUDY OF 802,457 PAROUS NORWEGIAN WOMEN [J].
ALBREKTSEN, G ;
HEUCH, I ;
KVALE, G .
BRITISH JOURNAL OF CANCER, 1995, 72 (02) :480-484
[3]   MAMMARY CANCERS AND PREGNANCY [J].
ANDERSON, JM .
BMJ-BRITISH MEDICAL JOURNAL, 1979, 1 (6171) :1124-1127
[4]  
[Anonymous], 1983, FEDERAL RESERVE BANK
[5]  
Ansquer Y, 2005, ANTICANCER RES, V25, P243
[6]   Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history:: A combined analysis of 22 studies [J].
Antoniou, A ;
Pharoah, PDP ;
Narod, S ;
Risch, HA ;
Eyfjord, JE ;
Hopper, JL ;
Loman, N ;
Olsson, H ;
Johannsson, O ;
Borg, Å ;
Pasini, B ;
Radice, P ;
Manoukian, S ;
Eccles, DM ;
Tang, N ;
Olah, E ;
Anton-Culver, H ;
Warner, E ;
Lubinski, J ;
Gronwald, J ;
Gorski, B ;
Tulinius, H ;
Thorlacius, S ;
Eerola, H ;
Nevanlinna, H ;
Syrjäkoski, K ;
Kallioniemi, OP ;
Thompson, D ;
Evans, C ;
Peto, J ;
Lalloo, F ;
Evans, DG ;
Easton, DF .
AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (05) :1117-1130
[7]   BONE SCANNING IN PREGNANT PATIENTS WITH BREAST-CARCINOMA [J].
BAKER, J ;
ALI, A ;
GROCH, MW ;
FORDHAM, E ;
ECONOMOU, SG .
CLINICAL NUCLEAR MEDICINE, 1987, 12 (07) :519-524
[8]   Progesterone enhances cytokine-stimulated nitric oxide synthase II expression and cell death in human breast cancer cells [J].
Bentrari, F ;
Arnould, L ;
Jackson, AP ;
Jeannin, JF ;
Pance, A .
LABORATORY INVESTIGATION, 2005, 85 (05) :624-632
[9]  
Beral V, 2004, LANCET, V363, P1007, DOI 10.1016/S0140-6736(04)15835-2
[10]   TREATMENT OF BREAST TUMORS ASSOCIATED WITH PREGNANCY AND LACTATION [J].
BYRD, BF ;
ROBERTSON, JC ;
STEPHENSON, SE ;
BAYER, DS .
ANNALS OF SURGERY, 1962, 155 (06) :940-+
12345678